We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Holley
HLLY
$319M
| $268K | ﹤0.01% |
60,162
-113,365
| -65% | -$518K |
|
2127
AN2 Therapeutics
ANTX
$178M
| $268K | ﹤0.01% |
82,498
-254,823
| -76% | -$2.77M |
|
|
STR
2128
DELISTED
Sitio Royalties
STR
| $268K | ﹤0.01% |
+10,824
| New | +$244K |
|
|
VCSA
2129
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $267K | ﹤0.01% |
+39,141
| New | +$319K |
|
2130
Indivior Pharmaceuticals
INDV
$4.73B
| $266K | ﹤0.01% |
+12,430
| New | +$233K |
|
2131
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $266K | ﹤0.01% |
2,800
-2,700
| -49% | -$251K |
|
|
CCRD
2132
DELISTED
CoreCard
CCRD
| $265K | ﹤0.01% |
23,956
-2,100
| -8% | -$25K |
|
2133
Red Violet
RDVT
$889M
| $261K | ﹤0.01% |
+13,358
| New | +$245K |
|
2134
Turkcell
TKC
$4.79B
| $260K | ﹤0.01% |
50,152
+3,883
| +8% | +$20.4K |
|
|
PPSI
2135
Pioneer Power Solutions
PPSI
$33.1M
| $260K | ﹤0.01% |
45,571
+31,408
| +222% | +$165K |
|
|
NVO
2136
Novo Nordisk
NVO
$220B
| $257K | ﹤0.01% |
2,000
-231,879
| -99% | -$27.6M |
|
2137
Teekay
TK
$974M
| $257K | ﹤0.01% |
+35,272
| New | +$276K |
|
2138
Chemed
CHE
$6.76B
| $257K | ﹤0.01% |
+400
| New | +$243K |
|
|
FLG
2139
Flagstar Bank National Association
FLG
$5.74B
| $256K | ﹤0.01% |
+26,538
| New | +$491K |
|
2140
iShares Asia 50 ETF
AIA
$4.51B
| $255K | ﹤0.01% |
+4,200
| New | +$241K |
|
|
DAO
2141
Youdao
DAO
$1.91B
| $255K | ﹤0.01% |
63,381
-30,703
| -33% | -$119K |
|
2142
Murphy USA
MUSA
$11.3B
| $252K | ﹤0.01% |
600
| – | – |
|
2143
XPEL
XPEL
$1.18B
| $249K | ﹤0.01% |
4,611
-3,849
| -45% | -$202K |
|
2144
Zumiez
ZUMZ
$328M
| $248K | ﹤0.01% |
+16,300
| New | +$278K |
|
2145
DLH Holdings
DLHC
$75.7M
| $247K | ﹤0.01% |
+18,630
| New | +$288K |
|
|
PL.WS
2146
CALL
DELISTED
Planet Labs PBC Warrants
PL.WS
| $247K | ﹤0.01% |
120,000
-30,000
| -20% | -$5.85K |
|
|
SGMO
2147
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $247K | ﹤0.01% |
+368,743
| New | +$267K |
|
2148
Southern Company
SO
$109B
| $247K | ﹤0.01% |
3,439
-1,574,752
| -100% | -$109M |
|
2149
Foghorn Therapeutics
FHTX
$305M
| $245K | ﹤0.01% |
+36,526
| New | +$203K |
|
2150
Oppenheimer Holdings
OPY
$1.18B
| $244K | ﹤0.01% |
+6,113
| New | +$238K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.